Prelude Capital Management’s Pfizer PFE Stock Holding History

Prelude Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-200,300	Closed	-$7.26M	–	1878
2021 Q1	$7.26M	Sell	200,300 -700	-0.3%	-$24.9K	0.19%	64
2020 Q4	$7.4M	Buy	+201,000	New	+$7.37M	0.19%	62
2019 Q4	–	Sell	-949	Closed	-$32K	–	2169
2019 Q3	$32K	Buy	+949	New	+$34.5K	﹤0.01%	1299
2019 Q2	–	Sell	-53,649	Closed	-$2.16M	–	2040
2019 Q1	$2.16M	Buy	+53,649	New	+$2.15M	0.12%	162
2016 Q4	–	Sell	-31,093	Closed	-$999K	–	1730
2016 Q3	$999K	Hold	31,093	–	–	0.1%	212
2016 Q2	$1.04M	Sell	31,093 -2,846	-8%	-$90.8K	0.15%	166
2016 Q1	$954K	Buy	+33,939	New	+$969K	0.13%	178
2015 Q1	–	Sell	-6,324	Closed	-$187K	–	2111
2014 Q4	$187K	Sell	6,324 -4,954	-44%	-$142K	0.03%	671
2014 Q3	$316K	Buy	+11,278	New	+$317K	0.04%	546
2013 Q3	–	Sell	-23,610	Closed	-$627K	–	1808
2013 Q2	$627K	Buy	+23,610	New	+$652K	0.13%	198

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Prelude Capital Management's PFE Position: Q1 2026 in Review

Prelude Capital Management increased its Pfizer (PFE) stake by 13% in Q1 2026, buying an estimated $402K and bringing the position to 134,252 shares worth $3.77M. The position accounts for 0.29% of the portfolio, ranked #86.

Prelude Capital Management first reported a position in PFE in Q2 2013 and has held it in 38 quarters since. The position peaked at $3.91M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Prelude Capital Management held 134,252 shares of Pfizer worth $3.77M as of Q1 2026.
Prelude Capital Management bought 15,110 Pfizer shares in Q1 2026, an estimated $402K.
Pfizer made up 0.29% of Prelude Capital Management's portfolio in Q1 2026, its #86 holding.
Prelude Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 38 quarters since.
Prelude Capital Management's Pfizer position peaked at $3.91M in Q4 2021.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.